Biggest News Aggregation in the World
📰 Stephen Kramer News

Page 3 - Stephen Kramer News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Stephen Kramer. Real-time updates on events, politics, business and more.

Bright Horizons Family Solutions Reports Third Quarter of 2023 Financial Results

01.11.2023 - Bright Horizons Family Solutions Inc. (NYSE: BFAM), a leading provider of high-quality early education and child care, family care solutions, and workforce education services designed to support working families and client employees across life and ...
United Kingdom United States Stephen Kramer Bright Horizons Family Solutions Inc Bright Horizons Family Solutions Exchange Commission

Employers embracing on-site child care

On-site child care has become the latest -- and often, priciest -- new way for businesses of all sizes to attract and keep employees. Thats particularly the case in understaffed industries such as manufacturing, retail and education that have struggled to find low-wage workers in communities where child care is often scarce.
New York United States San Diego Dan Figurski Jessica Brown Marni Mcdowell

Bright Horizons Family Solutions Announces Date of Third Quarter 2023 Earnings Release and Conference Call

Bright Horizons Family Solutions® Inc. will release results for the quarter ended September 30, 2023 on Wednesday, November 1, 2023, after the stock market closes. Following the release, the...
United Kingdom United States Stephen Kramer Bright Horizons Family Solutions Inc Bright Horizons Family Solutions Chief Executive Officer Stephen

FDA approves Exxua for depression treatment after multiple rejections over more than two decades

The U.S. Food and Drug Administration (FDA) on Thursday approved the medication Exxua to treat major depressive disorder – a significant step after a decades-long battle for approval. Exxua is unique for its ability to target the serotonin 1A receptor, which is a regulator of mood and emotion. In doing so, it avoids undesirable side…
United States Stephen Kramer Fabre Kramer Pharmaceuticals Bipolar Support Alliance Drug Administration Major Depressive Disorder
Source: yahoo.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Fabre-Kramer Pharmaceuticals Announces FDA Approval of EXXUA™, the First and Only Oral Selective 5HT1a Receptor Agonist for the Treatment of Major Depressive Disorder in Adults

/PRNewswire/ -- Fabre-Kramer Pharmaceuticals Inc. (Fabre-Kramer), a biopharmaceutical company committed to developing novel therapies to address unmet needs in...
United States Stephen Kramer Stephen Stahl Anitah Clayton University Of Virginia School Medicine Department Of Psychiatry Neurobehavioral Sciences

Fabre-Kramer Pharmaceuticals Announces FDA Approval of EXXUAtm, the First and Only Oral Selective 5HT1a Receptor Agonist for the Treatment of Major Depressive Disorder in Adults

Fabre-Kramer Pharmaceuticals Inc. (Fabre-Kramer), a biopharmaceutical company committed to developing novel therapies to address unmet needs in psychiatry and neurology, is pleased to announce that the U.S. Food and Drug Administration (FDA)...
United States Anitah Clayton Stephen Kramer Stephen Stahl Bipolar Support Alliance University Of Virginia School Medicine

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science